566 related articles for article (PubMed ID: 27554802)
1. Targeting the endocannabinoid system: future therapeutic strategies.
Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
[TBL] [Abstract][Full Text] [Related]
2. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
[TBL] [Abstract][Full Text] [Related]
3. The role of cannabinoid signaling in acute and chronic kidney diseases.
Barutta F; Bruno G; Mastrocola R; Bellini S; Gruden G
Kidney Int; 2018 Aug; 94(2):252-258. PubMed ID: 29706358
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
5. Modulating the endocannabinoid system in human health and disease--successes and failures.
Pacher P; Kunos G
FEBS J; 2013 May; 280(9):1918-43. PubMed ID: 23551849
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid signaling in health and disease.
Lu Y; Anderson HD
Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids, endocannabinoids, and cancer.
Hermanson DJ; Marnett LJ
Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
[TBL] [Abstract][Full Text] [Related]
9. Modern approaches to the development of synthetic cannabinoid receptor probes.
Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products.
An D; Peigneur S; Hendrickx LA; Tytgat J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709050
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
Han QW; Yuan YH; Chen NH
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid Receptors in Diabetic Kidney Disease.
Barutta F; Mastrocola R; Bellini S; Bruno G; Gruden G
Curr Diab Rep; 2018 Feb; 18(2):9. PubMed ID: 29399721
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
De Luca MA; Fattore L
Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
Río CD; Millán E; García V; Appendino G; DeMesa J; Muñoz E
Biochem Pharmacol; 2018 Nov; 157():122-133. PubMed ID: 30138623
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic opportunities through modulation of the endocannabinoid system.
Makriyannis A; Mechoulam R; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1068-71. PubMed ID: 15885714
[No Abstract] [Full Text] [Related]
18. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.
Lowe H; Toyang N; Steele B; Bryant J; Ngwa W
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502379
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.
Hryhorowicz S; Kaczmarek-Ryś M; Zielińska A; Scott RJ; Słomski R; Pławski A
Front Immunol; 2021; 12():790803. PubMed ID: 35003109
[TBL] [Abstract][Full Text] [Related]
20. Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease.
Cairns EA; Toguri JT; Porter RF; Szczesniak AM; Kelly ME
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):253-65. PubMed ID: 26565550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
